Recently, we developed a model to predict tumor recurrence after living donor liver transplantation (LT) (i.e., a model to predict tumor recurrence after living donor liver transplantation (MoRAL score)) using only two HCC-related tumor markers: protein induced by vitamin K absence-II (PIVKA-II) and AFP [21]. The gene discussed is AFP; the disease is neoplasm.